Certified Nurse-Midwives
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 9,188 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 7,316 |
| Established patient office or other outpatient visit, 30-39 minutes | 6,227 |
| Injection of drug or substance under skin or into muscle | 6,094 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 2,523 |
| Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 1,253 |
| Removal of impacted ear wax | 1,155 |
| Urinalysis, manual test | 1,149 |
| New patient office or other outpatient visit, 30-44 minutes | 823 |
| Established patient office or other outpatient visit, 10-19 minutes | 527 |
| Established patient office or other outpatient visit, 40-54 minutes | 438 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 418 |
| New patient office or other outpatient visit, 45-59 minutes | 383 |
| Insertion of needle into vein for collection of blood sample | 375 |
| Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | 335 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 327 |
| Aspiration and/or injection of fluid from large joint | 325 |
| Fluoroscopic guidance for needle placement | 317 |
| Fitting and insertion of vaginal support device | 300 |
| Automated urinalysis test | 248 |
| Testing for presence of drug, by chemistry analyzers | 210 |
| Assessment of emotional or behavioral problems | 169 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 166 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 154 |
| Smear for infectious agents | 151 |
| Stool analysis for blood to screen for colon tumors | 149 |
| Complete ultrasound scan of pelvis | 148 |
| Annual depression screening, 5 to 15 minutes | 139 |
| Telephone medical discussion with physician, 21-30 minutes | 127 |
| Removal of skin and tissue, 20.0 sq cm or less | 123 |
| Insertion of lower leg neurostimulator electrode | 105 |
| Insertion of temporary bladder tube | 89 |
| Bacterial colony count, urine | 87 |
| Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | 87 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 78 |
| New patient office or other outpatient visit, 60-74 minutes | 70 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 69 |
| Administration of influenza virus vaccine | 66 |
| Manual urinalysis test with examination using microscope, automated | 64 |
| Pessary, non rubber, any type | 61 |
| Detection test by immunoassay with direct visual observation for influenza virus | 60 |
| Screening mammography | 60 |
| X-ray of knee, 1-2 views | 58 |
| Emergency department visit with moderate level of medical decision making | 56 |
| Annual alcohol misuse screening, 5 to 15 minutes | 54 |
| Advance care planning, first 30 minutes | 47 |
| Screening 3d breast mammography | 46 |
| Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | 46 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 46 |
| Hemoglobin a1c level | 46 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 45 |
| Emergency department visit with low level of medical decision making | 45 |
| Biopsy of lining of uterus | 37 |
| New patient office or other outpatient visit, 15-29 minutes | 37 |
| Blood test, comprehensive group of blood chemicals | 36 |
| Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | 35 |
| Emergency department visit with high level of medical decision making | 32 |
| Blood test, lipids (cholesterol and triglycerides) | 32 |
| Body fluid ph level | 32 |
| Testing for presence of drug, read by direct observation | 32 |
| Vaginal fluid chemical analysis for bacteria | 31 |
| Telephone medical discussion with physician, 11-20 minutes | 31 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 31 |
| Detection test for candida species (yeast), amplified probe technique | 30 |
| Blood test, thyroid stimulating hormone (tsh) | 30 |
| X-ray of both knees while standing | 29 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 27 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 26 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 24 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 23 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 21 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 21 |
| Thyroid hormone, t3 measurement, total | 18 |
| Exam of external female genitals using an endoscope | 18 |
| Thyroxine (thyroid chemical), free | 18 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 18 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 17 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 |
| Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | 16 |
| Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 15 |
| Stool analysis for blood, by fecal hemoglobin determination by immunoassay | 14 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | 14 |
| Punch biopsy, first skin growth | 13 |
| Biopsy of growth of external female genitals, first growth | 13 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 13 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 13 |
| Detection test for candida species (yeast), direct probe technique | 12 |
| Telephone medical discussion with physician, 5-10 minutes | 12 |
| Detection test for gardnerella vaginalis (bacteria), direct probe technique | 12 |
| Admn sarscov2 vacc 1 dose | 11 |
| Hospital discharge day management, more than 30 minutes | 11 |
← Back to Certified Nurse-Midwives
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).